Abbott Laboratories

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-06-26 pm EDT			5-day change	1st Jan Change
104.9 ^USD	-0.58%		+0.86%	-4.72%

Jun. 20	Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	CI
Jun. 14	Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15	MT

Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on December 10, 2021.

May 02, 2024 at 04:11 pm EDT

From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 33,318,001 shares, representing 1.9% for $3,591.07 million under the buyback announced on December 10, 2021.

Latest news about Abbott Laboratories

Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health	Jun. 20	CI
Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15	Jun. 14	MT
Abbott Laboratories Declares Quarterly Common Dividend, Payable on August 15, 2024	Jun. 14	CI
Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems	Jun. 10	MT
US FDA clears Abbott's continuous glucose monitors for over-the-counter use	Jun. 10	RE
Abbott Receives U.S. FDA Clearance for Two New Over-The-Counter Continuous Glucose Monitoring Systems	Jun. 10	CI
U.S. FDA set to reorganize its food division starting October	May. 30	RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115	May. 30	MT
Medtronic beats quarterly profit estimates on medical devices strength	May. 23	RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating	May. 22	MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit	May. 15	MT
Drugmaker Abbott India posts Q4 profit rise on higher sales	May. 09	RE
Abbott Laboratories Insider Sold Shares Worth $2,428,119, According to a Recent SEC Filing	May. 08	MT
Tranche Update on Abbott Laboratories's Equity Buyback Plan announced on December 10, 2021.	May. 02	CI
Abbott Laboratories Announces Retirement of Robert E. Funck, Jr as Executive Vice President, Finance, Effective July 1, 2024	May. 01	CI
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee	Apr. 29	MT
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	Apr. 23	MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	Apr. 22	MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept	Apr. 19	MT
Correction to Health Care Roundup Article	Apr. 18	DJ
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating	Apr. 18	MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating	Apr. 18	MT
Health Care Down After Abbott Earnings -- Health Care Roundup	Apr. 17	DJ

Chart Abbott Laboratories

Duration

Period

More charts

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-14 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Abbott Laboratories

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

104.9 USD

Average target price

125.2 USD

Spread / Average Target

+19.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-4.72%	182B
MEDTRONIC PLC	-2.83%	103B
BECTON, DICKINSON AND COMPANY	-5.01%	66.94B
CENCORA, INC.	+15.53%	46.73B
DEXCOM, INC.	-8.53%	45.14B
HOYA CORPORATION	+5.82%	41.57B
METTLER-TOLEDO INTERNATIONAL, INC.	+17.67%	30.48B
TERUMO CORPORATION	+14.00%	24.26B
WEST PHARMACEUTICAL SERVICES, INC.	-8.08%	23.58B
ZIMMER BIOMET HOLDINGS, INC.	-11.17%	22.24B

Other Medical Equipment, Supplies & Distribution